Roles of TRPV1and Neuropeptidergic Receptors in Dorsal Root Reflex-Mediated Neurogenic Inflammation Induced by Intradermal Injection of Capsaicin
Open Access
- 1 January 2007
- journal article
- Published by SAGE Publications in Molecular Pain
- Vol. 3 (1) , 30
Abstract
Background: Acute cutaneous neurogenic inflammation initiated by activation of transient receptor potential vanilloid-1 (TRPV1) receptors following intradermal injection of capsaicin is mediated mainly by dorsal root reflexes (DRRs). Inflammatory neuropeptides are suggested to be released from primary afferent nociceptors participating in inflammation. However, no direct evidence demonstrates that the release of inflammatory substances is due to the triggering of DRRs and how activation of TRPV1receptors initiates neurogenic inflammation via triggering DRRs.Results: Here we used pharmacological manipulations to analyze the roles of TRPV1and neuropeptidergic receptors in the DRR-mediated neurogenic inflammation induced by intradermal injection of capsaicin. The degree of cutaneous inflammation in the hindpaw that followed capsaicin injection was assessed by measurements of local blood flow (vasodilation) and paw-thickness (edema) of the foot skin in anesthetized rats. Local injection of capsaicin, calcitonin gene-related peptide (CGRP) or substance P (SP) resulted in cutaneous vasodilation and edema. Removal of DRRs by either spinal dorsal rhizotomy or intrathecal administration of the GABAAreceptor antagonist, bicuculline, reduced dramatically the capsaicin-induced vasodilation and edema. In contrast, CGRP- or SP-induced inflammation was not significantly affected after DRR removal. Dose-response analysis of the antagonistic effect of the TRPV1receptor antagonist, capsazepine administered peripherally, shows that the capsaicin-evoked inflammation was inhibited in a dose-dependent manner, and nearly completely abolished by capsazepine at doses between 30–150 μg. In contrast, pretreatment of the periphery with different doses of CGRP8–37(a CGRP receptor antagonist) or spantide I (a neurokinin 1 receptor antagonist) only reduced the inflammation. If both CGRP and NK1receptors were blocked by co-administration of CGRP8–37and spantide I, a stronger reduction in the capsaicin-initiated inflammation was produced.Conclusion: Our data suggest that 1) the generation of DRRs is critical for driving the release of neuropeptides antidromically from primary afferent nociceptors; 2) activation of TRPV1receptors in primary afferent nociceptors following intradermal capsaicin injection initiates this process; 3) the released CGRP and SP participate in neurogenic inflammation.Keywords
This publication has 56 references indexed in Scilit:
- Role of the Na+-K+-2Cl−Cotransporter in the Development of Capsaicin-Induced Neurogenic InflammationJournal of Neurophysiology, 2006
- Sympathetic Modulation of Activity in Aδ- and C-Primary Nociceptive Afferents After Intradermal Injection of Capsaicin in RatsJournal of Neurophysiology, 2005
- Sympathetic Influence on Capsaicin-Evoked Enhancement of Dorsal Root Reflexes in RatsJournal of Neurophysiology, 2004
- The VR1 Antagonist Capsazepine Reverses Mechanical Hyperalgesia in Models of Inflammatory and Neuropathic PainThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Die neurogene Entzündung. II. Pathophysiologie und klinische ImplikationenAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie, 2002
- Cellular Mechanisms of Neurogenic InflammationThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Mechanisms of touch-evoked pain (allodynia): a new modelPain, 1996
- Neonatal Anti‐NGF Treatment Reduces the Aδ‐ and C‐Fibre Evoked Vasodilator Responses in Rat Skin: Evidence That Nociceptor Afferents Mediate Antidromic VasodilatationEuropean Journal of Neuroscience, 1992
- Algesia and local responses induced by neurokinin A and substance P in human skin and temporal musclePeptides, 1989
- Antidromic vasodilatation and neurogenic inflammationInflammation Research, 1988